SurModics (SRDX) Tops Q1 View By 5c; Guides
More News related to SRDX
- SurModics (SRDX) Misses Q4 EPS by 4c
- SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment
- SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4
More News related to Earnings
- Ericsson (ERIC) Selected as Exclusive Supplier to MTS Allstream for High Speed Network
- Peregrine Pharma (PPHMD) Says Study of Phosphatidylserine-Targeting Antibody Doubles Survival Times in Animals with Aggressive Brain Cancer
- Merit Medical Systems (MMSI) Receives U.S. FDA 510(K) Clearance for Merit Laureate Guide Wire
- Teva Pharma (TEVA) Announces Generic Version of Prevacid Does Not Infringe on Patents
- NTELOS Holdings (NTLS) Announces Workforce Reductions; Estimates $1.5M Cash Severance
SurModics, Inc. (Nasdaq: SRDX) reports Q1 EPS of $0.24, 5 cents better than the analyst estimate of $0.19. Revenue for the quarter was $20.9 million, versus the consensus of $20.49 million.
On track to achieve '09 goals.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
